Commercial Partners

MedCity (with HEFCE and GLA support) launched in April 2014 to promote and grow the world-leading life sciences cluster of England’s greater south east, by promoting life sciences investment, entrepreneurship and industry in the region. It acts as a facilitator and communicator to integrate the Centre’s aims and objectives, provide local leadership, encourage inward investment and nurture collaborative entrepreneurial activity. MedCity is also an essential ally in connecting industry, including pharma, large and small, with the Centre.

QMUL is also host to the Genomics England, 100,000 Genomes Programme, established by the Department of Health to undertake whole genome sequencing (WGS) of up to 100,000 NHS patients focused upon rare inherited disorders, cancer, and infectious disease.